Edgewise Therapeutics, Inc. (EWTX)

28.83 -0.87 (-2.93%) USD  |  NASDAQ  |  Mar 03, 16:00
28.83 0.00 (0.00%) After-Hours: 19:16
More

Edgewise Therapeutics Net Change in Capital Expenditures (% of Quarterly Assets)

Net Change in Capital Expenditures (% of Quarterly Assets) Chart

View Net Change in Capital Expenditures (% of Quarterly Assets) for EWTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years

View Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks

View Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks
Start Trial
Glaukos Corp. Upgrade
Nuvalent, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
Omeros Corp. Upgrade
Agios Pharmaceuticals, Inc. Upgrade